Carvajal Alejandra
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/05/2026
Type
OTHER
CytomX Therapeutics, Inc.
CTMX • Biotechnology
$2.52
▲ +0.01 (+0.40%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$551.73M
Growth
-4.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 3.09Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.52
Change0.40%
Shares Out218.94M
Market Cap$551.73M
Enterprise Value$227.15M
52W Range1.72 - 8.21
Beta2.09
P/E-6.93
P/S30.15
P/B1.83
P/FCF-5.11
EV/Sales12.41
Price$2.52
Change0.40%
Shares Out218.94M
Market Cap$551.73M
Enterprise Value$227.15M
52W Range1.72 - 8.21
Beta2.09
P/E-6.93
P/S30.15
P/B1.83
P/FCF-5.11
EV/Sales12.41
EV/EBITDA-2.80
EV/FCF-2.10
Earnings Yield-14.44%
FCF Yield-19.58%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-29.35%
Profit Margin-22.79%
Debt/Eq0.04
Current Ratio3.09
Quick Ratio3.09
Revenue 5Y-3.97%
Target$8.50
Target Upside237.30%
Target Median$8.50
Target Range6.00 - 11.00
Volume3.68M
Avg Volume4.13M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
46/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 3.09Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 21 analyst votes · 2026-10-20
90/100
Bullish
Bullish
17
Hold
4
Bearish
0
Price Target
2026-08-07
Low
$6.00
Mean
$11.25
Median
$11.50
High
$16.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Carvajal Alejandra
Transaction: 08/03/2026
BUY
Change
+100,000
Price
Not reported
Filing
08/05/2026
Type
BUY
Carvajal Alejandra
Transaction: 08/03/2026
BUY
Change
+450,000
Price
$3.17
Filing
08/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Carvajal Alejandra | OTHER | 0 | Not reported | 08/03/2026 | 08/05/2026 |
| Carvajal Alejandra | BUY | +100,000 | Not reported | 08/03/2026 | 08/05/2026 |
| Carvajal Alejandra | BUY | +450,000 | $3.17 | 08/03/2026 | 08/05/2026 |
| Fuchs Charles S. | OTHER | 0 | Not reported | 07/24/2026 | 07/30/2026 |
| Fuchs Charles S. | BUY | +118,000 | $3.24 | 07/24/2026 | 07/30/2026 |
| Jones Elaine V | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Ashworth Alan | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Gilbert Halley E | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Meyers James R | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Mohindru Mani | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Young Matthew P. | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Su Zhen | BUY | +59,000 | $2.96 | 06/17/2026 | 06/22/2026 |
| Ogden Christopher | SELL | -1,624 | $3.05 | 06/15/2026 | 06/17/2026 |
| Ogden Christopher | SELL | -19,323 | $6.42 | 03/17/2026 | 03/19/2026 |
| BELVIN MARCIA | SELL | -31,492 | $6.42 | 03/17/2026 | 03/19/2026 |
| McCarthy Sean A. | SELL | -118,969 | $6.42 | 03/17/2026 | 03/19/2026 |
| Chu Yu-Waye | SELL | -21,279 | $6.42 | 03/17/2026 | 03/19/2026 |
| McCarthy Sean A. | BUY | +980,000 | $6.09 | 02/02/2026 | 02/04/2026 |
| McCarthy Sean A. | BUY | +210,000 | Not reported | 02/02/2026 | 02/04/2026 |
| Ogden Christopher | BUY | +90,000 | Not reported | 02/02/2026 | 02/04/2026 |